Long-Lasting Gene Therapy Benefits Advanced Heart Failure Patients Science Daily (press release) 19, 2013 — Researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai reported the long-term benefits of a single dose of their gene therapy AAV1/SERCA2a in advanced heart failure patients on Nov. 19 at the ... |
